oncology cell

Oncology

We take on some of the toughest cancers with a single goal in mind: to help more patients around the world lead fuller, longer lives. We pioneer research across oncology. Developing new technologies and medicines has allowed us to reimagine patient treatments for solid tumours and blood cancers. 

Building on expertise to tackle the toughest cancers

Our scientific research has led to critical discoveries in the treatment of blood cancer. Building upon our strong commitment to patients and existing leadership, we are driving innovation in cancer research and treatment for both blood cancers and solid tumours.

Our robust portfolio is comprised of treatments and an advancing pipeline designed to tackle some of the most difficult-to-treat cancers.


Related content

Increasing awareness about blood cancers



Topics

Oncology focus areas

We are focusing on finding answers that transform the way cancer is treated. We want to find better, longer-lasting results across blood cancers and solid tumours. Our culture of curiosity drives us to uncover new solutions.


Blood cancers

Blood cancer is a disease that impacts blood-forming tissues (such as bone marrow) and inhibits the body's ability to fight off infection. Leukemia, lymphoma, and myeloma are the most common forms of blood cancer that are seen in patients.


Our Focus areas

Solid tumors

We are advancing an innovative solid tumour portfolio that tackles some of the most difficult-to-treat cancers. 


Our Focus areas
Related content

Global CLL Community Insights, a report with CLLAN, highlighting patient wellbeing and communication needs.